Predicting Glucose Trends for Population Management
Cerner Innovation, located in Kansas City MO, is developing computerized systems for predicting dangerous glucose levels based on glucose data associated with patients.
Cerner and CoverMyMeds have partnered to deliver point-of-care price transparency to physicians within the EHR prescribing interface. The partnership will put contextualized drug prices in front of the provider, who can then discuss these costs with patients. Holding conversations about medical costs, especially prescription drug costs, has been cited as a top strategy for driving better medication adherence.
Related Posts
Cala Health Claims to Have the only Patented Neurostimulation for Essential Tremor Treatment. The Patent Data Disagrees
Cala Health has figured out that innovations backed by patents make them exponentially more valuable in the marketplace. However, in a zest…
Capital One is Investing in AI Biotech? What’s in their wallet?
In the past 18 months, Capital One has expanded past its usual banking activities, and begun exploring the AI Biotech Sector. But do they…
Google AI Reinvents Speech Recognition. Who will follow?
There is no doubt that the big 5 tech companies (Apple, Amazon, Google, Facebook, and Microsoft) have developed massive IP portfolios in…